Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 9/20 | 0.72 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.72 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.72 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.72 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.72 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.72 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.72 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.72 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.49 |
| ▸ | NOS1 | P29475 | 6/20 | 0.48 |
| ▸ | NOS2 | P35228 | 2/20 | 0.43 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7449583 | 1.00 | SIGMAR1 (0.72) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL7435027 | 0.88 | SIGMAR1 (0.71) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL7435022 | 0.88 | SIGMAR1 (0.71) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL6720780 | 0.84 | SIGMAR1 (1.00) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| Acetamidine SCHEMBL7442851 | 0.82 | SIGMAR1 (0.71) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| Acetamidine SCHEMBL7442858 | 0.82 | SIGMAR1 (0.71) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL1696515 | 0.76 | AOC3 (0.62) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL14367991 | 0.75 | SIGMAR1 (0.55) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL6720775 | 0.74 | SIGMAR1 (0.57) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL27644958 | 0.73 | GRIN2D (0.56) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5552443-A | TREATMENT OF PSYCHOSIS, ANXIETY AND AS HYPOTENSIVE AGENTS | OREGON HEALTH SCIENCES UNIVERSITY (US) | 1996-09-03 | — | — | US | disclosed |
| EP-0551330-A4 | SUBSTITUTED AMIDINES HAVING HIGH BINDING TO THE SIGMA RECEPTOR AND THE USE THEREOF | OREGON STATE (US) | 1994-07-06 | — | — | EP | disclosed |
| US-5308869-A | TREATMENT OR PROPHYLAXIS OF ANXIETY IN AN ANIMAL | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION (US) | 1994-05-03 | — | — | US | disclosed |
| EP-0551330-A1 | SUBSTITUTED AMIDINES HAVING HIGH BINDING TO THE SIGMA RECEPTOR AND THE USE THEREOF | The STATE OF OREGON acting by and through the STATE BOARD OF HIGHER EDUCATION on behalf of the UNIV. OF OREGON (US) | 1993-07-21 | — | — | EP | disclosed |
| WO-1992004054-A1 | SUBSTITUTED AMIDINES HAVING HIGH BINDING TO THE SIGMA RECEPTOR AND THE USE THEREOF | STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY, PORTLAND, OREGON, and THE UNIVERSITY OF OREGON, EUGENE, OREGON, Johnson Hall, University of Oregon (US) | 1992-03-19 | — | — | WO | disclosed |